Insider Stock Trading History of Aberman Michael S


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Aberman Michael S since year 2005. The trader's CIK number is 1487767. At the time of this reporting, Aberman Michael S is the SVP Strategy Investor Relation of Regeneron Pharmaceuticals Inc . (stock ticker symbol REGN). See this page for all insider trading activities at Regeneron Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Aberman Michael S since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-06-22 REGN Regeneron Pharmaceuticals Inc Sale 2,269 533.05 1,209,488
2017-06-21 REGN Regeneron Pharmaceuticals Inc Option Ex 4,500 30.63 137,835
2015-12-17 REGN Regeneron Pharmaceuticals Inc Option Ex 4,000 24.00 96,000
2015-03-24 REGN Regeneron Pharmaceuticals Inc Sale 4,843 478.60 2,317,879
2015-03-17 REGN Regeneron Pharmaceuticals Inc Option Ex 11,398 24.00 273,552
2015-03-18 REGN Regeneron Pharmaceuticals Inc Sale 3,442 467.69 1,609,802
2015-02-23 REGN Regeneron Pharmaceuticals Inc Option Ex 7,500 30.63 229,725
2015-02-24 REGN Regeneron Pharmaceuticals Inc Sale 3,374 418.41 1,411,701
2015-02-13 REGN Regeneron Pharmaceuticals Inc Option Ex 7,500 24.00 180,000
2015-02-17 REGN Regeneron Pharmaceuticals Inc Sale 3,692 404.02 1,491,641
2014-08-22 REGN Regeneron Pharmaceuticals Inc Option Ex 3,000 24.00 72,000
2014-08-18 REGN Regeneron Pharmaceuticals Inc Option Ex 8,750 52.03 455,262
2014-08-19 REGN Regeneron Pharmaceuticals Inc Sale 3,611 350.00 1,263,850
2014-02-14 REGN Regeneron Pharmaceuticals Inc Option Ex 7,500 30.63 229,725
2014-02-18 REGN Regeneron Pharmaceuticals Inc Sale 3,648 329.79 1,203,055
2013-06-17 REGN Regeneron Pharmaceuticals Inc Option Ex 3,900 24.00 93,600
2013-05-14 REGN Regeneron Pharmaceuticals Inc Sale 5,529 280.07 1,548,507
2013-05-13 REGN Regeneron Pharmaceuticals Inc Option Ex 12,500 24.00 300,000
2013-05-06 REGN Regeneron Pharmaceuticals Inc Option Ex 8,334 24.00 200,016
2013-05-06 REGN Regeneron Pharmaceuticals Inc Sale 8,334 256.88 2,140,796
2012-12-18 REGN Regeneron Pharmaceuticals Inc Option Ex 1,200 24.00 28,800
2012-12-10 REGN Regeneron Pharmaceuticals Inc Option Ex 7,500 30.63 229,725
2012-12-11 REGN Regeneron Pharmaceuticals Inc Sale 3,368 185.01 623,130
2012-11-30 REGN Regeneron Pharmaceuticals Inc Sale 3,904 182.37 711,956
2012-11-29 REGN Regeneron Pharmaceuticals Inc Option Ex 8,334 24.00 200,016
2012-05-24 REGN Regeneron Pharmaceuticals Inc Option Ex 500 24.00 12,000
2012-04-30 REGN Regeneron Pharmaceuticals Inc Option Ex 12,500 24.00 300,000
2012-05-01 REGN Regeneron Pharmaceuticals Inc Sale 6,162 134.91 831,284
2011-09-06 REGN Regeneron Pharmaceuticals Inc Option Ex 8,334 24.00 200,016
2011-09-07 REGN Regeneron Pharmaceuticals Inc Sale 3,377 69.04 233,137
2011-09-02 REGN Regeneron Pharmaceuticals Inc Option Ex 4,166 24.00 99,984
2011-09-02 REGN Regeneron Pharmaceuticals Inc Sale 4,166 64.00 266,624

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aberman Michael S (SVP Strategy Investor Relation of Regeneron Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.